Dun Liang
Global Regulatory Affairs, Diagnostics Eli Lilly & Co.
Seminars
Monday 22nd September 2025
Panel Discussion: Why Diagnostic Regulation Matters in Pharmaceutical Development, & Current Best Practices
5:40 pm
- Identifying the role of diagnostics in pharmaceutical development and the corresponding levels of regulatory expectation
- Providing a high-level summary and comparison of related regulations globally
- Outlining best practices for aligning diagnostic and therapeutic development processes to foster innovation and ensure patient access to precision therapies
